MicroRNAs (miR) play important roles in cancer invasion. In this study, we investigated the role of miR-21 in the invasion of renal cell carcinoma. The invasive abilities of renal carcinoma cell lines (786-O, Caki-1, A498), one normal epithelial kidney cell line (HK-2) and primary renal carcinoma cells were assessed in a microfluidic model. The expression of miR-21 was examined by quantitative real time PCR (qRT-PCR). We found that HK-2 cells with low miR-21 expression showed low invasive ability while renal carcinoma cell lines with high miR-21 expression showed high invasive ability. Primary renal cancer cells showed higher invasive ability than HK-2 cells, and this was consistent with the level of miR-21 expression. miR-21 knockdown reduced both renal carcinoma cell line and primary cancer cell invasion. Overall, this study shows that miR-21 promotes renal cancer cell invasion in both cell lines and primary cancer cells and suggests that miR-21 might be a new target in renal cancer therapy. In addition, we demonstrate that a microfluidic device provides a useful in vitro platform to study cancer cell invasion.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Wang, X., Jin, Y., Wang, W., Yu, N., Xiao, X., Liu, T., & Li, X. (2017). MiRNA-21 promotes renal carcinoma cell invasion in a microfluidic device. RSC Advances, 7(70), 44124–44131. https://doi.org/10.1039/c7ra01768e